Dr. Gary J. Kennedy answers the question: 'Lamotrigine For Bipolar Disorder?' — -- Question: How is lamotrigine (Lamictal) used in the treatment of bipolar disorder? What are the side effects and ...

May 14, 2009 — Lamotrigine (Lamictal, GlaxoSmithKline) orally disintegrating tablets (ODT) have been approved by the US Food and Drug Administration (FDA) for maintenance treatment of bipolar 1 ...

Publication bias, especially the lack of publication of negative treatment studies, is known to be a major problem in the medical literature. In particular, it appears that the pharmaceutical industry ...

LOS ANGELES -- The FDA's warning about arrhythmia risk with lamotrigine (Lamictal) based on in vitro data wasn't borne out in observational cohorts of people with epilepsy, although the risk did ...

Lamotrigine is indicated as monotherapy or adjunctive therapy for epilepsy and for use as maintenance treatment in patients with bipolar I disorder. Following a review of in vitro study findings, the ...

According to the largest and only prospective placebo-controlled study in patients with rapid cycling bipolar disorder (manic depression), a drug called lamotrigine is safe and effective in preventing ...

Combining lamotrigine with quetiapine improves the treatment of depressive symptoms in patients with bipolar disorder, with the benefits maintained for at least a year, show findings from the CEQUEL ...

If you or somebody you care for takes the anticonvulsant drug lamotrigine (Lamictal and generic), you should be aware that in rare cases it can cause inflammation of the membranes that cover the brain ...

One lot of epilepsy and bipolar disorder tablets got recalled Friday after someone discovered a cross-contamination with a drug used in heart and blood pressure medication, according to the FDA-posted ...

The FDA on Wednesday updated its warning about potential increased arrhythmia risk in people with cardiac disease who are taking the seizure and mental health drug lamotrigine (Lamictal) with new data ...

Q: I am a clinical nurse specialist who has submitted 37 adverse-event reports to the Food and Drug Administration regarding generic lamotrigine. Most involved a loss of response, but many involved ...